Surgical Treatment for Refractory Epilepsy: Review of Patient Evaluation and Surgical Options
Overview
Authors
Affiliations
Treatment of epilepsy often imposes an exposure to various antiepileptic drugs and requires long-term commitment and compliance from the patient. Although many new medications are now available for the treatment of epilepsy, approximately 30% of epilepsy patients still experience recurrent seizures and many experience undesirable side effects. Treatment of epilepsy requires a multidisciplinary approach. For those patients with medically refractory seizures, surgical treatment has increased in prevalence as techniques and devices improve. With increased utilization, proper patient selection has become crucial in evaluating appropriateness of surgical intervention. Epilepsy syndromes in which surgery has shown to be effective include mesial temporal sclerosis, cortical dysplasia, many pediatric epilepsy syndromes, and vascular malformations. Monitoring in an epilepsy monitoring unit with continuous scalp or intracranial EEG is an important step in localization of seizure focus. MRI is the standard imaging technique for evaluation of anatomy. However, other imaging studies including SPECT and PET have become more widespread, often offering increased diagnostic value in select situations. In addition, as an alternative or adjunct to surgical resection, implantable devices such as vagus nerve stimulators, deep brain stimulators, and direct brain stimulators could be useful in seizure treatment.
The cingulum: a central hotspot for the battle against chronic intractable pain?.
Kollenburg L, Arnts H, Green A, Strauss I, Vissers K, Vinke S Brain Commun. 2024; 6(5):fcae368.
PMID: 39479369 PMC: 11522883. DOI: 10.1093/braincomms/fcae368.
Das K, Sen J, Borode A Cureus. 2024; 16(8):e67591.
PMID: 39310452 PMC: 11416750. DOI: 10.7759/cureus.67591.
Miao Y, Iimura Y, Sugano H, Fukumori K, Tanaka T Cogn Neurodyn. 2023; 17(6):1591-1607.
PMID: 37969944 PMC: 10640557. DOI: 10.1007/s11571-022-09915-x.
Statsenko Y, Babushkin V, Talako T, Kurbatova T, Smetanina D, Simiyu G Biomedicines. 2023; 11(9).
PMID: 37760815 PMC: 10525492. DOI: 10.3390/biomedicines11092370.
Changes in lipid profiles of epileptic mouse model.
Johnson A, Grove R, Madhavan D, Boone C, Braga C, Kyllo H Metabolomics. 2020; 16(10):106.
PMID: 33021695 PMC: 10614666. DOI: 10.1007/s11306-020-01729-4.